Form 3 Avalo Therapeutics, Inc. For: Dec 01 Filed by: Chan Mitchell

December 3, 2021 8:43 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Chan Mitchell

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Avalo Therapeutics, Inc. [ AVTX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
Christopher R. Sullivan, by Power of Attorney 12/03/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Know all by these presents, 
that the undersigned hereby 
constitutes and appoints 
Christopher Sullivan and 
Jennifer Zoltoski of Avalo 
Therapeutics, Inc. (the "Company") 
with full power of substitution, 
the undersigned's true and 
lawful attorney-in-fact to:
(1)prepare, execute in the 
undersigned's name and on 
the undersigned's behalf, 
and submit to the U.S. 
Securities and Exchange Commission 
(the "SEC") a Form ID, 
including amendments thereto, 
and any other documents necessary 
or appropriate to obtain codes 
and passwords enabling the 
undersigned to make electronic 
filings with the SEC of 
reports required by Section 
16(a) of the Securities 
Exchange Act of 1934 or 
any rule or regulation of the SEC;

(2)execute for and on behalf 
of the undersigned, in the 
undersigned's capacity as 
an officer, director 
and/or trustee of the 
Company, Forms 3, 4, 
and 5 in accordance 
with Section 16(a) 
of the Securities Exchange 
Act of 1934 and the 
rules thereunder;

(3)do and perform any 
and all acts for and 
on behalf of the 
undersigned which may 
be necessary or desirable 
to complete and execute 
any such Form 3, 4, or 5, 
complete and execute any 
amendment or amendments 
thereto, and timely file 
such form with the 
SEC and any stock exchange 
or similar authority; and

(4)take any other action 
of any type whatsoever in 
connection with the foregoing 
which, in the opinion of such 
attorney-in-fact, may be of 
benefit to, in the best interest 
of, or legally required by, 
the undersigned, it being 
understood that the documents 
executed by such attorney-in-fact 
on behalf of the undersigned 
pursuant to this Power of Attorney 
shall be in such form and shall 
contain such terms and conditions 
as such attorney-in-fact may 
approve in such attorney-in-fact's 
The undersigned hereby grants 
to such attorney-in-fact full 
power and authority to 
do and perform any and 
every act and thing 
whatsoever requisite, 
necessary, or proper to 
be done in the exercise 
of any of the rights and 
powers herein granted, 
as fully to all intents 
and purposes as the 
undersigned might or could 
do if personally present, 
with full power of substitution 
or revocation, hereby ratifying 
and confirming all that such 
attorney-in-fact, or such 
attorney-in-fact's substitute 
or substitutes, shall lawfully 
do or cause to be done by 
virtue of this power of attorney 
and the rights and powers 
herein granted.  The undersigned 
acknowledges that the foregoing 
attorney-in-fact, in serving in 
such capacity at the request 
of the undersigned, are not 
assuming, nor is the 
Company assuming, any of 
the undersigned's responsibilities 
to comply with Section 16 of 
the Securities Exchange Act of 1934.
This Power of Attorney shall 
remain in full force and effect 
until the undersigned is 
no longer required to 
file Forms 3, 4, and 5 
with respect to the undersigned's 
holdings of and transactions 
in securities issued by the 
Company, unless earlier 
revoked by the undersigned 
in a signed writing delivered 
to the foregoing attorneys-in-fact. 
This Power of Attorney revokes 
all prior Powers of Attorney 
given by the undersigned with 
respect to the matters addressed 
in (1) through (4) above.
IN WITNESS WHEREOF, the undersigned 
has caused this Power of Attorney 
to be executed as of this 
1st day of December 2021.
/s/ Mitchell Chan

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings